retatrutide phase 2 study results Weight loss with as compared to licenced obesity Retatrutide vs Tirzepatide (2026): Differences

Most patients lose 1020% of body weight with consistent use and provider guidance

Hepatic GCGR activation stimulates gluconeogenesis while simultaneously reducing hepatic fat content through inhibition of de novo lipogenesis and promotion of mitochondrial fatty acid oxidation

And I also wanna remind you, you don't have to share your medical history with anyone

What dosing schedule and titration plan are you recommending, and what should I do if I experience side effects

GLP-1, short for glucagon-like peptide-1 , is a hormone your body naturally produces after you eat

It is not intended for human or animal administration, diagnostic use, therapeutic use, dietary use, or consumption of any kind.